FDA Approves Weight-loss Drug Zepbound For Sleep Apnea – Will Insurance Cover This $1000-Per-Month Medication?
Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...
You can't cure sleep apnea but you can manage it — doctors explain how
Obstructive sleep apnea is a condition that disrupts rest, leading to symptoms such as daytime fatigue, brain fog and ...
Neurology Advisor1d
Zepbound Approved for Obstructive Sleep Apnea in Patients With Obesity
The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with obesity.
Lilly's Zepbound to be covered by Medicare for sleep apnea
Eli Lilly's (NYSE:LLY) weight-loss drug Zepbound is now reportedly covered by Medicare for the treatment of obstructive sleep ...
Hosted on MSN3d
New imaging technique could transform obstructive sleep apnea diagnosis
Obstructive sleep apnea (OSA) is a common sleep disorder characterized by intermittent airway blockages during sleep, leading ...
Optical imaging technique offers more precise diagnosis of sleep apnea
Obstructive sleep apnea (OSA) is a common sleep disorder characterized by intermittent airway blockages during sleep, leading ...
abp LIVE9d
Why A Kolkata Clinic Is Advocating for Insurance Coverage for Sleep Disorders
Major health insurance providers in India — both public and private — exclude sleep disorders from their plans. This coverage ...
Daily11d
CPAP treatment lowers mortality in stroke and TIA in patients with sleep disorders: Study
A new study published in the Journal of Stroke and Cardiovascular Disease showed that continuous positive airway pressure (CPAP) has been linked to a lower all-cause death rate in patients ...
People18d
Zepbound Weight Loss Medication Approved by FDA to Treat Sleep Apnea
The FDA also recommends that prescribed users reduce their caloric intake and increase their exercise Charna Flam is a writer-reporter at PEOPLE. She has been working at PEOPLE since 2023.
McKnight's Long-Term Care News18d
FDA approves Zepbound for sleep apnea in patients with obesity
(HealthDay News) — The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA). In a news ...
Medscape19d
Obesity Drug Zepbound Approved for Obstructive Sleep Apnea
The US Food and Drug Administration (FDA) has approved the obesity treatment tirzepatide (Zepbound, Eli Lilly) for treating moderate to severe obstructive sleep apnea (OSA) in adults with obesity.